Other top stories

Understanding Neurotransmitters in Schizophrenia Beyond Dopamine

October 30, 2024

Mindfulness Therapy Offers Hope for PTSD in Cardiac Arrest Survivors

October 29, 2024

Cholinergic Neurotransmission’s Role in Schizophrenia Symptoms

October 28, 2024

Aerobic Exercise Might Help ‘Chemo Brain’ Symptoms

October 25, 2024

Weekly Mind Reader: Rethinking BPD

October 25, 2024

Trauma Appears To Alter How We Process Memories

October 23, 2024

Other stories

Researchers Identify Variables Driving PTSD in Traumatized Youth

October 21, 2024

Weekly Mind Reader: Clinicians Tackle Psychedelics

October 18, 2024

Why Are We Convinced We Know What We Don’t?

October 18, 2024

Managing Weight, Metabolic Syndrome, and Diabetes in Schizophrenia Patients

October 17, 2024

Growing Interest in Cannabinoids for PTSD Yields Mixed Results

October 16, 2024

Esketamine Nasal Spray Offers Help for Treatment-Resistant Depression

October 15, 2024

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe